Found 10 matching trials
Type 3 Von Willebrand International Registries Inhibitor Prospective Study N/A International Registries and Prospective Study on Type 3 Von Willebrand's D...
Show More Location
Helsinki University Central Hospital, Department Internal Medicine, Coagulation Disorders, at Haematology and Laboratory Services
Learn More & Join Trial
Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate N/A Von Willebrand disease (VWD) is the most common inherited bleeding disorder...
Show More Location
Assiut university
Learn More & Join Trial
Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment N/A The purpose of this study is to prospectively obtain reliable data on the b...
Show More Location
Children's Healthcare of Atlanta
Learn More & Join Trial
Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) NA The purpose of this study is to evaluate whether a concentrate containing b...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients PHASE4 The purpose of this study is to assess the role of a FVIII/VWF complex conc...
Show More Location
Ain Shams Pediatric hospital, Ain Shams University
Learn More & Join Trial
Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive NA This is a prospective, controlled, randomized, open label study, aimed at c...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients N/A International, post-authorisation non-interventional study to evaluate real...
Show More Location
University of Miami Miller School of Medicine
Learn More & Join Trial
Survey of Inhibitors in Plasma-Product Exposed Toddlers PHASE4 The primary objective of the study is to assess the immunogenicity of VWF/F...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease PHASE3 This is a Phase III, multicenter, open-label clinical study designed to eva...
Show More Learn More & Join Trial
An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment N/A This non-interventional study (NIS) is designed to collect information on t...
Show More Status
Active Not Recruiting
Learn More & Join Trial